Elbit Med Tech (EMTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Elbit Med Tech (EMTC) has a cash flow conversion efficiency ratio of -0.003x as of June 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-116.00K ≈ $-310.99 USD) by net assets (ILA39.07 Million ≈ $104.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Elbit Med Tech - Cash Flow Conversion Efficiency Trend (2008–2022)
This chart illustrates how Elbit Med Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Elbit Med Tech carry for a breakdown of total debt and financial obligations.
Elbit Med Tech Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Elbit Med Tech ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VULTUS AB
F:V06
|
N/A |
|
Frontier Developments Plc
LSE:FDEV
|
0.291x |
|
Greenlite Ventures Inc.
NASDAQ:GRNLD
|
N/A |
|
Tasfoods Ltd
AU:TFL
|
-0.576x |
|
Smartfren Telecom Tbk
JK:FREN
|
-0.016x |
|
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
|
0.106x |
|
Ortin Global Limited
NSE:ORTINGLOBE
|
-0.597x |
|
Fuse Cobalt Inc
V:FUSE
|
-0.057x |
Annual Cash Flow Conversion Efficiency for Elbit Med Tech (2008–2022)
The table below shows the annual cash flow conversion efficiency of Elbit Med Tech from 2008 to 2022. For the full company profile with market capitalisation and key ratios, see EMTC market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | ILA25.01 Million ≈ $67.05K |
ILA-526.00K ≈ $-1.41K |
-0.021x | -17.39% |
| 2021-12-31 | ILA30.53 Million ≈ $81.86K |
ILA-547.00K ≈ $-1.47K |
-0.018x | -22.43% |
| 2020-12-31 | ILA46.06 Million ≈ $123.48K |
ILA-674.00K ≈ $-1.81K |
-0.015x | -194.02% |
| 2019-12-31 | ILA-36.69 Million ≈ $-98.36K |
ILA-571.00K ≈ $-1.53K |
0.016x | -51.67% |
| 2018-12-31 | ILA-15.49 Million ≈ $-41.54K |
ILA-499.00K ≈ $-1.34K |
0.032x | +353.51% |
| 2017-12-31 | ILA-42.38 Million ≈ $-113.63K |
ILA-301.00K ≈ $-806.97 |
0.007x | -23.32% |
| 2016-12-31 | ILA-31.64 Million ≈ $-84.81K |
ILA-293.00K ≈ $-785.52 |
0.009x | -52.52% |
| 2015-12-31 | ILA-13.38 Million ≈ $-35.87K |
ILA-261.00K ≈ $-699.73 |
0.020x | +104.38% |
| 2014-12-31 | ILA995.00K ≈ $2.67K |
ILA-443.00K ≈ $-1.19K |
-0.445x | -815.76% |
| 2013-12-31 | ILA6.91 Million ≈ $18.53K |
ILA-336.00K ≈ $-900.80 |
-0.049x | -173.42% |
| 2009-12-31 | ILA-141.63 Million ≈ $-379.72K |
ILA-9.38 Million ≈ $-25.14K |
0.066x | -26.36% |
| 2008-12-31 | ILA-119.95 Million ≈ $-321.59K |
ILA-10.79 Million ≈ $-28.92K |
0.090x | -- |
About Elbit Med Tech
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of magnetic and focused imaging equipment in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurologica… Read more